• 농업과학연구
• /
• 제26권1호
• /
• pp.31-38
• /
• 1999

한국인의 기호에 맞으며 약리적인 효능을 가지고 있는 인삼을 인삼 extract, 백삼분 및 미삼분의 형태로 요구르트 제조시에 첨가하고 제품의 산생성도, 유산균수, 점도, 관능검사 및 보존성 등을 시험한 결과는 다음과 같다. 1. 인삼 extract, 백삼분 및 미삼분을 첨가한 호상 요구르트의 시험제조 결과 산도는 무첨가구의 0.95%에 비하여 인삼첨가구 특히 미삼 첨가구가 1.13%로서 가장 높았다. 2. 유산균수에 있어서는 무첨가구의 $6.5{\times}10^8/ml$에 비하여 첨가구 특히 미삼첨가구가 $9.8{\times}10^8/ml$로서 가장 높았다. 3. 제품의 점성은 무첨가구에 비하여 첨가구 특히 백삼첨가구가 가장 높았다. 4. 제품의 관능검사 결과 맛과 향취에 있어서는 인삼첨가구가 우수하였고 조직에 있어서는 무첨가구가 우수하였으며 전체적인 기호도에 있어서는 미삼첨가구가 우수하였다. 5. 제품의 보존시험에 있어서는 $5^{\circ}C$, 10일간 보존에서 pH, 산도 및 유산균수의 변화가 크게 나타나지 않았다.

• 한국식품영양학회지
• /
• 제3권1호
• /
• pp.9-12
• /
• 1990

Toxohormone-L is a lipolytic factor, found in ascites fluid of sarcoma 180-bearing mice and of patients with hepatoma. A substance that inhibited the lipolytic action of toxohormone-L was isolated from white ginseng powder. This substance was an acidic polysaccharides It inhibited toxohormone-L-induced lipolysis in a dose dependent manner at concentrations higher than 100g/ml.

• Journal of Ginseng Research
• /
• 제6권2호
• /
• pp.138-142
• /
• 1982

The composition and concentration of ginsenosides and the free sugars in panax ginseng(Korea ginseng), panax quinquefolium (American ginseng) and panax pseudoginseng var. notoginseng (Sanchi ginseng), were investigated. The major ginsenosides and the order of their amount in panax ginseng are Rbl, Rc Rgl, Re, Rb2 Rd and these are about 90% of total ginsenosides, but major ginsenosides of American and Snachi ginseng art Rbl, Re, Rg1 (about 91% of total) ansi Rgl, Rbl, Re (about 93% of total) respectively. Sanchi ginseng was observed in higher concentration of panaxatriol than panaxadiol unlike panax and American ginseng. Free sugars in white ginseng are fructose, glucose, maltose and sucrose. Whereas, in red ginseng rhamnose and xylose were also detected as free sugar.

• Journal of Ginseng Research
• /
• 제37권4호
• /
• pp.475-482
• /
• 2013

The main active components of Panax ginseng are ginsenosides. Ginsenoside Rb1 and Rg1 are accepted as marker substances for quality control worldwide. The analytical methods currently used to detect these two compounds unfairly penalize steamed and dried (red) P. ginseng preparations, because it has a lower content of those ginsenosides than white ginseng. To manufacture red ginseng products from fresh ginseng, the ginseng roots are exposed to high temperatures for many hours. This heating process converts the naturally occurring ginsenoside Rb1 and Rg1 into artifact ginsenosides such as ginsenoside Rg3, Rg5, Rh1, and Rh2, among others. This study highlights the absurdity of the current analytical practice by investigating the time-dependent changes in the crude saponin and the major natural and artifact ginsenosides contents during simmering. The results lead us to recommend (20S)- and (20R)-ginsenoside Rg3 as new reference materials to complement the current P. ginseng preparation reference materials ginsenoside Rb1 and Rg1. An attempt has also been made to establish validated qualitative and quantitative analytical procedures for these four compounds that meet International Conference of Harmonization (ICH) guidelines for specificity, linearity, range, accuracy, precision, detection limit, quantitation limit, robustness and system suitability. Based on these results, we suggest a validated analytical procedure which conforms to ICH guidelines and equally values the contents of ginsenosides in white and red ginseng preparations.

• Mass Spectrometry Letters
• /
• 제12권1호
• /
• pp.16-20
• /
• 2021

We aimed to compare the content of ginsenosides and the pharmacokinetics after the oral administration of four different ginseng products at a dose of 1 g/kg in rats. The four different ginseng products were fresh ginseng extract, red ginseng extract, white ginseng extract, and saponin enriched white ginseng extract prepared from the radix of Panax ginseng C.A. Meyer. The ginsenoside concentrations in the ginseng product and the rat plasma samples were determined using a liquid chromatography-tandem mass spectrometry (LC-MS/MS). Eight or nine ginsenosides of the 15 tested ginsenosides were detected; however, the content and total ginsenosides varied depending on the preparation method. Moreover, the content of triglycosylated ginsenosides was higher than that of diglycosylated ginsenosides, and deglycosylated ginsenosides were not present in any preparation. After the single oral administrations of four different ginseng products in rats, only four ginsenosides, such as 20(S)-ginsenosides Rb1 (GRb1), GRb2, GRc, and GRd, were detected in the rat plasma samples among the 15 ginsenosides tested. The plasma concentrations of GRb1, GRb2, GRc, and GRd were different depends on the preparation method but pharmacokinetic features of the four ginseng products were similar. In conclusion, a good correlation between the area under the concentration curve and the content of GRb1, GRb2, and GRc, but not GRd, in the ginseng products was identified and it might be the result of their higher content and intestinal biotransformation of the ginseng product.

• 한국식품과학회지
• /
• 제28권5호
• /
• pp.922-927
• /
• 1996

수삼으로 제조된 백삼 제품들의 가공방법의 차이에 따른 성분 변화에 대한 조사로서 원료삼인 수삼과 전통적인 방법으로 제조한 백삼, 태극삼 A, 새로운 방법으로 제조된 태극삼 B의 일반성분, 추출수율, 사포닌 함량 및 조성, 유리당 조성을 비교 분석 하였다. 4가지 시료의 조단백질은 13.34-15.33%, 조지방은 1.04-2.05%, 조회분은 3.13-5.25%, 총 식이섬유는 9.72-15.46%, 당질은 64.75-73.48% 범위의 함량이었다. 추출수율은 열수 추출이 80% 메탄올 추출보다 전체적으로 약 2배 이상 높게 나타났으며, 가공하지 않은 수삼의 열수 추출 수율이 56.4%로 가장 높았다. 사포닌 함량은 열수 추출시 수삼의 총 사포닌이 2.40%로 가장 많이 추출되었으며, 태극삼 A는 태극삼 B보다 비율로 볼 때 약 20% 이상 적은 1.45%의 총 사포닌 함량을 나타내었다. Ginsenoside 조성은 열수 추출시 $ginsenoside-Rg_1$이 수삼은 36.52%이지만 태극삼 A와 B는 68.66, 67.89%고 약 2배의 함량을 나타내었다. $Ginsenoside-Rb_1$은 태극삼 A차 B에 18.41, 17.43%만이 함유되어 있었다. 한편 태극삼 A와 태극삼 B의 총 사포닌 양에는 큰 차이가 있었지만 ginsenosides의 조성비에 있어서는 서로 큰 차이가 없는 것으로 나타났다. 80% 메탄올 추출의 경우에도 가공방법이 다르게 제조된 백삼 제품별로 ginsenoside조성에 큰 차이를 나타내었다. 수삼과 백삼에서는 열수 추출과 80% 메탄올 추출 모두에서 함량비는 다를지라도 fructose, glucose, sucrose, maltose만이 함유되어 있었지만 열 처리된 태극삼 A와 B에는 rhamnose도 각각 2.56, 4.01%씩 함유되어 있었다.

• Journal of Ginseng Research
• /
• 제29권3호
• /
• pp.138-144
• /
• 2005

본 연구에서는 high fat diet에 대한 인삼 추출물의 항산화 효과를 알아보기 위해 실험동물로 생쥐를 이용하였다. 대조군은 일반사료만을, FD군은 high fat diet만을 먹였으며, 실험군은 high fat diet와 인삼추출물을 경구 투여한 후 간 조직에서의 SOD, catalase, GPS의 활성 및 MDA 및 $H_2O_2$ 함량 등을 측정함으로서 fat diet독성에 대한 지질과산화와의 상호 관련성, 인삼의 항산화 효소의 효과를 비교 검토하였다. Fat diet 독성에 대한 항산화 효소인 SOD의 활성은 인삼 추출물 군에서 전반적으로 낮았으며, GPx의 활성은 FR500, FR3000군에서 가장 높은 결과를 보였다. 과산화수소 함량은 FD군에서 약간 높았지만, 모든 군에서 거의 유사한 결과를 보였다. 자유라디칼에 의해 생성된 지질과산화의 최종 산물인 MDA의 함량은 FD군을 기준으로 인삼추출물 군에서 모두 낮은 수치를 보였다. 이와 같이 fat diet에 대한 인삼 추출물은 SOD의 활성 증대보다는 자유라디칼 제거제로서 항산화 효과를 보였다고 생각하고, GPx의 직접적인 작용과 생체 내에서 내인성 항산화 물질인 GSH의 합성 능력을 강화시킴으로서 산화적 손상에 대한 방어기전을 향상시키는 결과라고 생각한다.

• 동의생리병리학회지
• /
• 제27권6호
• /
• pp.795-801
• /
• 2013

The purpose of this study is to investigate effects of White Ginseng-Ejung-tang (EG) and Red Ginseng-Ejung-tang (ER) water extract on production of various cytokines such as interleukin (IL)-21, IL-25, IL-$28{\beta}$, erythropoietin (EPO), Exodus-2, monocyte chemotactic protein (MCP)-5, macrophage inflammatory protein (MIP)-$3{\alpha}$, MIP-$3{\beta}$, Fractalkine, and TARC in RAW 264.7 mouse macrophages stimulated by lipopolysaccharide (LPS). Levels of cytokines were measured by High-throughput multiplex bead array cytokine assay based on xMAP (multi-analyte profiling beads) technology. ER significantly decreased levels of IL-21, IL-25, IL-$28{\beta}$, EPO, Exodus-2, MCP-5, MIP-$3{\alpha}$, MIP-$3{\beta}$, TARC, and fractalkine for 24 h incubation at the oncentrations of 25 and 100 ${\mu}g/mL$ in LPS-induced RAW 264.7 (P < 0.05). But EG did not show any significant effect. These results suggest that ER has anti-inflammtory property related with its inhibition on the production of IL-21, IL-25, IL-$28{\beta}$, and chemokines such as EPO, MCP-5, MIP-$3{\alpha}$, MIP-$3{\beta}$, Fractalkine, Exodus-2, and TARC in LPS-induced macrophages.

• Journal of Ginseng Research
• /
• 제21권1호
• /
• pp.53-60
• /
• 1997

The changes in aldehyde dehydrogenase(ALDH, E.C. 1.2.1.3.) activity in neurons and astrocytes isolated from rat brains were investigated after administration of ethanol and Korean red ginseng(Panax ginseng C.A. Meyer) saponln. The cerebral ALDH activity with acetaldehyde and Propionaldehyde was higher in the white matter than in the gray matter. However, using indole-3-a-cetaldehyde and 3,4-dihydroxyphenylacetaldehyde as substrates, there was no significant difference in activity between two regions in cerebrum. In ethanol treated group, ALDH activity with all the substrates in the gray and white matter was lower than in normal group. In ethanol-saponin treated group, the enzyme activity in the white matter remarkably Increased. The ALDH activity in neurons isolated from cerebral cortex in ethanol-treated group was lower than in normal group. In ethanol-saponin treated group, neuronal ALDH activity with propionaldehyde was significantly recovered but not with Indole-3-acetaldehyde. In astrocytes, although the ALDH activity with propionaldehyde in the ethanol-treated group was not changed as compared with normal group, considerable increase in activity was found in ethanol-saponin treated group. These results suggest that Korean red ginseng saponin may protect the neuronal functions from the toxic effects of acetaldehyde derived from ethanol by stimulation of ALDH activity in astrocytes surrounding nerve cells.

• Journal of Ginseng Research
• /
• 제45권1호
• /
• pp.191-198
• /
• 2021

Background: Most clinical studies of immune responses activated by Korean Red Ginseng (KRG) have been conducted exclusively in patients. However, there is still a lack of clinical research on immune-boosting benefits of KRG for healthy persons. This study aims to confirm how KRG boosts the immune system of healthy subjects. Methods: A total of 100 healthy adult subjects were randomly divided into two groups that took either a 2 g KRG tablet or a placebo per day for 8 weeks. The primary efficacy evaluation variables included changes in T cells, B cells, and white blood cells (WBCs) before and after eight weeks of KRG ingestion. Cytokines (TNF-α, INF-γ, IL-2 and IL-4), WBC differential count, and incidence of colds were measured in the secondary efficacy evaluation variables. Safety evaluation variables were used to identify changes in laboratory test results that incorporated adverse reactions, vital signs, hematological tests, blood chemistry tests, and urinalysis. Results: Compared to the placebo group, the KRG intake group showed a significant increase in the number of T cells (CD3) and its subtypes (CD4 and CD8), B cells, and the WBC count before and after eight weeks of the intake. There were no clinically significant adverse reactions or other notable results in the safety evaluation factors observed. Conclusion: This study has proven through its eight-week intake test and subsequent analysis that KRG boosts the immune system through an increase in T cells, B cells, and WBCs, and that it is safe according to the study's safety evaluation.